Showing results (251-260 of 368) with videos related to
Sort By:
Pageof 37
The American Journal of Cardiology|July 28, 2004
Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study)Georgios I Papaioannou, Richard L Seip, Neil J Grey, et al.Circulation. Heart Failure|May 19, 2023
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF TrialsMichael E Nassif, Sheryl L Windsor, Kensey Gosch, et al.European Journal of Heart Failure|February 22, 2021
Effect of dapagliflozin on anaemia in DAPA-HFKieran F Docherty, James P Curtain, Inder S Anand, et al.Diabetes, Obesity & Metabolism|February 19, 2021
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trialMichael E Nassif, Sheryl L Windsor, Fengming Tang, et al.JACC. Heart Failure|January 4, 2023
Blood Pressure and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: DELIVERSenthil Selvaraj, Muthiah Vaduganathan, Brian L Claggett, et al.Circulation|May 16, 2020
Empagliflozin in Heart Failure: Diuretic and Cardiorenal EffectsMatthew Griffin, Veena S Rao, Juan Ivey-Miranda, et al.Journal of the American College of Cardiology|August 30, 2022
Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart FailureMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.Circulation|June 24, 2018
Heart Failure After Ischemic Stroke or Transient Ischemic Attack in Insulin-Resistant Patients Without Diabetes Mellitus Treated With PioglitazoneLawrence H Young, Catherine M Viscoli, Gregory G Schwartz, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|June 6, 2006
Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imagingGeorgios I Papaioannou, Christos Kasapis, Richard L Seip, et al.JAMA Cardiology|October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical TrialMuthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.Pageof 37